Cargando…
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial
BACKGROUND: The ANCA-associated vasculitides (AAV) are systemic autoimmune inflammatory disorders characterised by necrotising inflammation affecting small to medium-sized blood vessels. Despite improvements in survival, infection and cardiovascular disease remain leading causes of morbidity and mor...
Autores principales: | Chanouzas, Dimitrios, Dyall, Lovesh, Nightingale, Peter, Ferro, Charles, Moss, Paul, Morgan, Matthew David, Harper, Lorraine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957324/ https://www.ncbi.nlm.nih.gov/pubmed/27450392 http://dx.doi.org/10.1186/s13063-016-1482-2 |
Ejemplares similares
-
The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis
por: Chanouzas, Dimitrios, et al.
Publicado: (2018) -
Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
por: King, C., et al.
Publicado: (2022) -
Rituximab 500 mg 6-monthly infusions is an option in maintenance
therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021) -
Subclinical Reactivation of Cytomegalovirus Drives CD4(+)CD28(null) T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Chanouzas, Dimitrios, et al.
Publicado: (2019) -
Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
por: Chanouzas, Dimitrios, et al.
Publicado: (2019)